TY - JOUR
T1 - Cognitive performance and all-cause mortality in community dwellers of Amerindian ancestry living in rural Ecuador
T2 - A population-based, longitudinal prospective study
AU - Del Brutto, Oscar H.
AU - Rumbea, Denisse A.
AU - Costa, Aldo F.
AU - Patel, Maitri
AU - Sedler, Mark J.
AU - Mera, Robertino M.
N1 - Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2024/1
Y1 - 2024/1
N2 - Objective: There is limited information on mortality risk in individuals with cognitive impairment living in rural Latin America. In this study, we assess the association between cognitive impairment and all-cause mortality in adults of Amerindian ancestry living in rural Ecuador. Patients and methods: Middle-aged and older adults enrolled in the population-based Three Villages Study cohort were followed prospectively in order to estimate mortality risk according to their baseline cognitive performance as determined by the Montreal Cognitive Assessment (MoCA). Results were adjusted for demographics, level of education, traditional cardiovascular risk factors, symptoms of depression, severe tooth loss, and oily fish intake (factors previously associated with mortality in the study population). Results: Analysis included 1022 individuals followed for an average of 7.8 ± 3.4 years. Mean MoCA score was 21.2 ± 5.4 points (median: 22 points), with 334 (32.7%) individuals showing cognitive impairment, as evidenced by a MoCA score ≤ 19 points (the cutoff for poor cognitive performance based on previous studies in the same population). A total of 150 (14.7%) individuals died during the follow-up. Crude mortality rate was 2.87 per 100 person-years (95% C.I.: 2.08 – 3.96). For individuals with normal cognition, the mortality rate was 1.21 (95% C.I.: 0.92 – 1.50) while for those with cognitive impairment the rate increased to 3.48 (95% C.I.: 2.73 – 4.23). A multivariate Cox-proportional hazards model, confirmed that individuals with cognitive impairment had a significantly higher mortality risk than those without cognitive impairment (HR: 1.52; 95% C.I.: 1.05 – 2.18). Conclusions: Cognitive impairment is associated with mortality in the study population.
AB - Objective: There is limited information on mortality risk in individuals with cognitive impairment living in rural Latin America. In this study, we assess the association between cognitive impairment and all-cause mortality in adults of Amerindian ancestry living in rural Ecuador. Patients and methods: Middle-aged and older adults enrolled in the population-based Three Villages Study cohort were followed prospectively in order to estimate mortality risk according to their baseline cognitive performance as determined by the Montreal Cognitive Assessment (MoCA). Results were adjusted for demographics, level of education, traditional cardiovascular risk factors, symptoms of depression, severe tooth loss, and oily fish intake (factors previously associated with mortality in the study population). Results: Analysis included 1022 individuals followed for an average of 7.8 ± 3.4 years. Mean MoCA score was 21.2 ± 5.4 points (median: 22 points), with 334 (32.7%) individuals showing cognitive impairment, as evidenced by a MoCA score ≤ 19 points (the cutoff for poor cognitive performance based on previous studies in the same population). A total of 150 (14.7%) individuals died during the follow-up. Crude mortality rate was 2.87 per 100 person-years (95% C.I.: 2.08 – 3.96). For individuals with normal cognition, the mortality rate was 1.21 (95% C.I.: 0.92 – 1.50) while for those with cognitive impairment the rate increased to 3.48 (95% C.I.: 2.73 – 4.23). A multivariate Cox-proportional hazards model, confirmed that individuals with cognitive impairment had a significantly higher mortality risk than those without cognitive impairment (HR: 1.52; 95% C.I.: 1.05 – 2.18). Conclusions: Cognitive impairment is associated with mortality in the study population.
KW - Amerindians
KW - Cognitive impairment
KW - Cognitive performance
KW - Montreal cognitive assessment
KW - Mortality
KW - Population-based study
UR - https://www.scopus.com/pages/publications/85177833775
U2 - 10.1016/j.clineuro.2023.108053
DO - 10.1016/j.clineuro.2023.108053
M3 - Artículo
C2 - 37992533
AN - SCOPUS:85177833775
SN - 0303-8467
VL - 236
JO - Clinical Neurology and Neurosurgery
JF - Clinical Neurology and Neurosurgery
M1 - 108053
ER -